📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Safety and Immunogenicity of the ChAdox1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 in HIV Infection (2021)

First Author: Frater J

Attributed to: Natural Killer Cells as Effectors in HIV Cure Strategies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.3829931

Publication URI: http://dx.doi.org/10.2139/ssrn.3829931

Type: Journal Article/Review

Parent Publication: SSRN Electronic Journal